Edition:
United Kingdom

GlaxoSmithKline Pharmaceuticals Ltd (GLAX.NS)

GLAX.NS on National Stock Exchange of India

1,319.15INR
7:47am GMT
Change (% chg)

Rs0.05 (+0.00%)
Prev Close
Rs1,319.10
Open
Rs1,319.90
Day's High
Rs1,333.25
Day's Low
Rs1,300.10
Volume
10,704
Avg. Vol
13,954
52-wk High
Rs1,800.05
52-wk Low
Rs1,010.00

Revenue & Earnings Per Share

 
*Note: Units in Millions ofRupee
**Note: Units in Rupee

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 1 8,176.00 8,176.00 8,176.00 --
Year Ending Mar-19 6 32,558.80 33,724.00 31,949.00 34,503.40
Year Ending Mar-20 6 36,611.70 39,476.00 34,643.00 39,153.30
Earnings (per share)
Year Ending Mar-19 6 25.10 26.80 24.00 25.53
Year Ending Mar-20 6 30.60 36.50 26.55 30.66
Sales and Profit Figures in India Rupee (INR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 62.45 29.30 32.54
P/E High - Last 5 Yrs. -- 43.23 48.15
P/E Low - Last 5 Yrs. -- 22.71 23.42
Beta 0.17 0.86 0.87
Price to Sales (TTM) 14.01 6.59 8.39
Price to Book (MRQ) -- 5.12 5.27
Price to Tangible Book (MRQ) -- 5.84 6.74
Price to Cash Flow (TTM) 174.34 23.07 24.12
% Owned Institutions -- 0.87 1.65

Dividends

  Company industry sector
Dividend Yield 1.24 1.43 1.35
Dividend Yield - 5 Year Avg -- 1.45 1.37
Dividend 5 Year Growth Rate -- 3.99 4.70
Payout Ratio(TTM) 0.00 42.18 39.60

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 5.43 13.45
Sales (TTM) vs TTM 1 Yr. Ago -- 6.61 8.02
Sales - 5 Yr. Growth Rate -- 10.48 10.85
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 45.67 47.68
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 9.91 10.47
Capital Spending - 5 Yr. Growth Rate -- 15.26 14.68

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.07 2.18
Current Ratio (MRQ) -- 2.87 2.98
LT Debt to Equity (MRQ) -- 8.87 11.35
Total Debt to Equity (MRQ) -- 12.87 16.02
Interest Coverage (TTM) -- 32.47 28.44

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 23.80 52.10 52.41
Gross Margin - 5 Yr. Avg. -- 49.66 50.39
EBITD Margin (TTM) 29.85 -- --
EBITD - 5 Yr. Avg -- 17.26 12.43
Operating Margin (TTM) 33.89 13.53 5.77
Operating Margin - 5 Yr. Avg. -- 13.69 8.02
Pre-Tax Margin (TTM) 33.89 11.90 4.80
Pre-Tax Margin - 5 Yr. Avg. -- 14.11 8.31
Net Profit Margin (TTM) 23.12 8.81 1.53
Net Profit Margin - 5 Yr. Avg. -- 10.60 4.72
Effective Tax Rate (TTM) 31.77 22.12 22.13
Effective Tax Rate - 5 Yr. Avg. -- 22.26 22.58

Efficiency

  Company industry sector
Revenue/Employee (TTM) 3,109,462 928,329,244 820,307,647
Net Income/Employee (TTM) 718,922 105,132,028 92,854,588
Receivable Turnover (TTM) -- 5.84 5.82
Inventory Turnover (TTM) -- 2.57 3.41
Asset Turnover (TTM) -- 0.93 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 10.98 10.60
Return on Assets - 5 Yr. Avg. -- 12.41 11.78
Return on Investment (TTM) -- 14.23 13.82
Return on Investment - 5 Yr. Avg. -- 16.18 15.32
Return on Equity (TTM) -- 15.46 15.25
Return on Equity - 5 Yr. Avg. -- 17.07 16.41
  1 Year 3 Year 5 Year
Sales % 5.71 -- --
EPS (TTM) % -10.46 -- --
Dividend % -40.00 -- --
Note: Units in Millions of US Dollars

Performance for GlaxoSmithKline Pharmaceuticals Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -2.25 -2.64 99 31
13 Week -6.52 -7.86 99 42
26 Week -11.71 -17.56 99 45
52 Week -17.27 -26.91 99 9
YTD -11.53 -25.96 99 37
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 12.63%
# of Holders: 21
Total Shares Held: 21,395,381
3 Mo. Net Change: 1,648,845
# New Positions: 2
# Closed Positions: 0
# Increased Positions: 5
# Reduced Positions: 4
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.